Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized phase 2 trial.
AuteursDe Caluwé A, Desmoulins I, Cao K, Remouchamps V, Baten A, Longton E, Peignaux K, Joaquin Garcia A, Venet D, Arecco L, Agostinetto E, Nader-Marta G, Denis Z, Dhont J, Kristanto P, Catteau X, Larsimont D, Salgado R, Poortmans P, Stagg J, Sotiriou C, Piccart M, Ignatiadis M, Romano E, Buisseret L
Acute brain dysfunction clusters in COVID-19: a pilot machine learning-based analysis of the COVID-D cohort.
AuteursRomero-García N, Montosa-I-Micó V, Fernández-Narro D, García-Gómez JM, Hurtado L, Passariello E, Taccone FS, Robba C, Raman R, Orun OM, Pandharipande P, Pun BT, Ely EW, Badenes R, Sáez C
The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions.
AuteursZotano ÁG, Allweis TM, Foerster R, Palmieri C, Gluz O, Chia S, Sotiriou C, Bianchini G
What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group.
AuteursErdem S, Amparore D, Re C, Verep S, Capitanio U, Larcher A, Roussel E, Klatte T, Bertolo R, Muselaers S, Pavan N, Kara O, Ingels A, Pecoraro A, Marchioni M, Pandolfo SD, Diana P, Carbonara U, Mollica V, Warren H, Borregales L, Marandino L, Sharma G, Caliò A, Wu Z, Lovati LA, Ciccarese C, Margue G, Francolini G, Flippot R, Leung DK, Mjaess G, Rosiello G, Mir MC, Palumbo C, Campi R
